Business Description
Benitec Biopharma Inc
NAICS : 325412
SIC : 2834
ISIN : AU000000BLT8
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 39.95 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -6.56 | |||||
Beneish M-Score | 1.8 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -91.3 | |||||
3-Year Book Growth Rate | -32.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 60.22 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | -33.33 | |||||
12-1 Month Momentum % | -71.43 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.18 | |||||
Quick Ratio | 4.18 | |||||
Cash Ratio | 4.11 | |||||
Days Sales Outstanding | 2815.71 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 17.5 | |||||
Shareholder Yield % | 0.31 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 1600 | |||||
Operating Margin % | -307028.57 | |||||
Net Margin % | -309885.71 | |||||
FCF Margin % | -311066.67 | |||||
ROE % | -200.14 | |||||
ROA % | -142.54 | |||||
ROIC % | -1493.74 | |||||
3-Year ROIIC % | -2613.43 | |||||
ROC (Joel Greenblatt) % | -3829.62 | |||||
ROCE % | -196.12 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2110 | |||||
PB Ratio | 2 | |||||
Price-to-Tangible-Book | 1 | |||||
EV-to-EBIT | -3.3 | |||||
EV-to-EBITDA | -3.35 | |||||
EV-to-Revenue | 10230.06 | |||||
EV-to-FCF | -3.53 | |||||
Earnings Yield (Greenblatt) % | -30.28 | |||||
FCF Yield % | -23.74 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Benitec Biopharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.006 | ||
EPS (TTM) (€) | 0 | ||
Beta | 0 | ||
Volatility % | 96.31 | ||
14-Day RSI | 0 | ||
14-Day ATR (€) | 0 | ||
20-Day SMA (€) | 0 | ||
12-1 Month Momentum % | -71.43 | ||
52-Week Range (€) | 0.01 - 0.09 | ||
Shares Outstanding (Mil) | 321.29 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Benitec Biopharma Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Benitec Biopharma Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Benitec Biopharma Inc Frequently Asked Questions
What is Benitec Biopharma Inc(FRA:BJ9)'s stock price today?
When is next earnings date of Benitec Biopharma Inc(FRA:BJ9)?
Does Benitec Biopharma Inc(FRA:BJ9) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |